TDF + LNG Vaginal Ring
Alternative Name: Tenofovir Disoproxil Fumarate (TDF) + Levonorgestrel Vaginal Ring
Product Details
Duration: 30 days
Regimen:
Active Pharmaceutical Ingredient (API):
Inactive material: polyurethane
Status Details
Developer: , ,
Status Details: - A clinical trial conducted in 2014 in New York evaluated the ring in 60 women over 14 days. The trial assessed the ring's safety and measured how much of the drug is released and the properties of the ring after use.
- Another phase I trial began in 2017 to evaluate the safety of the ring over 84 days. The trial was not completed.
- A clinical trial conducted in 2014 in New York evaluated the ring in 60 women over 14 days. The trial assessed the ring's safety and measured how much of the drug is released and the properties of the ring after use.
- Another phase I trial began in 2017 to evaluate the safety of the ring over 84 days. The trial was not completed.
Additional Information
References: Press release: http://www.sciencedaily.com/releases/2013/09/130927123509.htm
Clinicaltrials.gov Identified NCT02006264
Clinicaltrials.gov Identified NCT02762617
Press release: http://www.sciencedaily.com/releases/2013/09/130927123509.htm
Clinicaltrials.gov Identified NCT02006264
Clinicaltrials.gov Identified NCT02762617